These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6147377

  • 1. 10 years experience with consecutive measurement of thyrotropin binding inhibiting antibodies (TBIAb).
    Hensen J, Kotulla P, Finke R, Badenhoop K, Koppenhagen K, Meinhold H, Schleusener H.
    J Endocrinol Invest; 1984 Jun; 7(3):215-20. PubMed ID: 6147377
    [Abstract] [Full Text] [Related]

  • 2. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y, Takamatsu J, Sakane S, Hirai K, Kuma K, Ohsawa N.
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis.
    Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, Katayama S, Ito K.
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):445-53. PubMed ID: 9640411
    [Abstract] [Full Text] [Related]

  • 6. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
    Schleusener H, Schernthaner G, Mayr WR, Kotulla P, Bogner U, Finke R, Meinhold H, Koppenhagen K, Wenzel KW.
    J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
    [Abstract] [Full Text] [Related]

  • 7. Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.
    Morita S, Izumi M, Nagataki S.
    Acta Endocrinol (Copenh); 1986 Aug; 112(4):517-22. PubMed ID: 2875588
    [Abstract] [Full Text] [Related]

  • 8. Ability of monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera.
    Rotella CM, Zonefrati R, Toccafondi R, Valente WA, Kohn LD.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):357-67. PubMed ID: 2416769
    [Abstract] [Full Text] [Related]

  • 9. Methodological aspects and clinical results of an assay for thyroid-stimulating antibodies: correlation with thyrotropin binding-inhibiting antibodies.
    Hensen J, Kotulla P, Finke R, Bogner U, Badenhoop K, Meinhold H, Schleusener H.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):980-7. PubMed ID: 6144692
    [Abstract] [Full Text] [Related]

  • 10. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M, Kaneko K, Kamoi K.
    J Med Case Rep; 2017 Feb 06; 11(1):32. PubMed ID: 28162094
    [Abstract] [Full Text] [Related]

  • 11. [A study of biological and histological criteria of thyroid autoimmunity in diffuse goiters with hyperthyroidism].
    Leprat F, Felicie-Dellan E, Trouette H, Latapie MJ, Masson B, De Mascarel A, Latapie JL, Roger P.
    Ann Endocrinol (Paris); 1997 Feb 06; 58(5):393-8. PubMed ID: 9685997
    [Abstract] [Full Text] [Related]

  • 12. Detectability of thyroid anti-microsomal antibodies, changes in thyroid-stimulating immunoglobulins (TSI) and thyrotropin-binding-inhibiting immunoglobulins (TBII) during methimazole treatment of Graves' disease patients.
    Szabó J, Leövey A, Karányi Z, Várvölgyi C, Fórizs E, Herceg L.
    Acta Med Hung; 1989 Feb 06; 46(1):23-30. PubMed ID: 2570399
    [Abstract] [Full Text] [Related]

  • 13. Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease.
    Gamstedt A, Wadman B, Karlsson A.
    J Clin Endocrinol Metab; 1986 Apr 06; 62(4):773-7. PubMed ID: 2869050
    [Abstract] [Full Text] [Related]

  • 14. Clinical role of TSH binding inhibiting antibodies (TBIAb) assay.
    Rubello D, Girelli ME, Piccolo M, Franzelin F, Betterle C, Busnardo B.
    J Nucl Med Allied Sci; 1990 Apr 06; 34(1):29-33. PubMed ID: 2384822
    [Abstract] [Full Text] [Related]

  • 15. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K.
    Thyroid; 2000 Sep 06; 10(9):809-13. PubMed ID: 11041459
    [Abstract] [Full Text] [Related]

  • 16. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
    Takasu N, Yamashiro K, Komiya I, Ochi Y, Sato Y, Nagata A.
    Thyroid; 2000 Oct 06; 10(10):891-6. PubMed ID: 11081255
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [99mTc uptake and TSH receptor autoantibodies--comparative study in Basedow's disease and other thyroid diseases].
    Baum RP, Happ J, Maul FD, Standke R, Hör G.
    Nuklearmedizin; 1985 Jun 06; 24(3):141-5. PubMed ID: 2997753
    [Abstract] [Full Text] [Related]

  • 19. [Cytologic differentiation between the autonomous and autoimmune type of diffuse hyperthyroid goiter: correlation with TSH receptor antibodies, microsomal antibodies and infiltrative ophthalmopathy].
    Smoje J, Bistrović D, Ugrai V, Gall D.
    Lijec Vjesn; 1989 Dec 06; 111(12):437-9. PubMed ID: 2636304
    [Abstract] [Full Text] [Related]

  • 20. Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.
    Smyth PP, McMullan NM, Grubeck-Loebenstein B, O'Donovan DK.
    Acta Endocrinol (Copenh); 1986 Mar 06; 111(3):321-30. PubMed ID: 2870597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.